查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379093

吸入麻醉市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球吸入麻醉市場規模達16億美元。展望未來， IMARC Group預計到2028年市場規模將達到19億美元，2022-2028年複合年成長率（CAGR）為2.9%。慢性疾病的盛行率日益上升，製藥公司、醫療器材製造商和醫療機構之間的合作，以及政府和私人醫療保健提供者對最先進設備的投資不斷增加，是推動市場的一些主要因素。

吸入麻醉是一種醫療技術，用於使接受各種外科手術的患者進入可逆的意識喪失和對疼痛不敏感的狀態。此方法涉及透過呼吸面罩或放置在患者氣道中的氣管內管以氣體或蒸氣形式施用麻醉劑。這些麻醉劑，如一氧化二氮、七氟醚、異氟醚和地氟醚，經過仔細平衡，以達到所需的鎮靜和疼痛緩解水平，同時維持重要的身體功能。吸入的麻醉藥物通過患者的呼吸系統，到達肺部，然後進入血液，最終影響大腦和中樞神經系統。

需要手術治療的慢性疾病的日益普及正在推動全球市場的發展。此外，隨著經濟的發展和個人更好地獲得醫療保健服務，醫療保健支出往往會增加。這包括對醫療設備和技術（包括麻醉設備）的投資。政府和私人醫療保健提供者願意投資最先進的設備，以改善病患照護和安全。此外，與病人安全和麻醉實踐相關的法規和指南可能會影響所使用的麻醉劑和設備的類型。市場成長通常與遵守這些法規一致，這可以導致採用更新的技術和代理。此外，製藥公司、醫療器材製造商和醫療機構之間的合作可以促進新麻醉技術的開發和推廣，推動市場擴張。此外，熟練的麻醉專業人員對於安全有效地實施吸入麻醉至關重要。培訓計劃和維持一支合格的麻醉人員隊伍的努力可能會影響對這些技術的需求。

吸入麻醉市場趨勢/促進因素：

麻醉劑和輸送系統的不斷進步

製藥公司和醫療設備製造商正在大力投資研發，以創造更有效、更安全的麻醉氣體和蒸氣。這些創新旨在透過降低不良反應的風險和改善整體麻醉體驗來提高患者的治療效果。正在開發具有改進的藥物動力學特徵的新型藥物，能夠更快地誘導和甦醒，從而縮短患者在手術室的時間。此外，複雜的輸送系統（包括精確的蒸發器和監控技術）的開發可確保麻醉劑的準確給藥和滴定，最大限度地減少劑量過量或不足的可能性。這些進步不僅有助於更好的患者護理，還吸引醫療保健提供者採用這些現代解決方案，從而促進吸入麻醉市場的成長。

手術數量和患者數量不斷增加

人口成長通常伴隨著人口老化，與外科手術需求的增加直接相關。由於與年齡相關的疾病，例如心血管疾病、關節置換和癌症治療，老年人口往往需要更多的醫療干預。因此，骨科、心臟病學、腫瘤學和一般外科等外科專業的需求增加。由於起效快且鎮靜深度可控，吸入麻醉被證明是這些手術的首選。它在確保患者失去知覺和維持其生理穩定性之間提供了平衡。此外，醫學知識和技術的擴展拓寬了可行手術介入的範圍。微創手術、機器人輔助手術和其他創新技術的出現，使得介入措施更加安全快速。

擴建門診手術中心

ASC 具有許多優勢，例如成本效益、縮短患者住院時間以及降低院內感染的風險。吸入麻醉起效快、恢復快，非常符合 ASC 的要求。在 ASC 接受手術的患者通常更喜歡吸入麻醉，因為這樣可以讓他們更快恢復日常活動。此外，吸入麻醉能夠最大限度地減少術後噁心和嘔吐，這在門診環境中特別有價值。隨著ASC數量的成長以滿足門診手術不斷成長的需求，吸入麻醉的需求預計將大幅增加。這一趨勢也鼓勵製造商開發更攜帶、更方便用戶使用的麻醉輸送系統，以滿足 ASC 的獨特需求。

吸入麻醉產業細分：

IMARC Group提供了全球吸入麻醉市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用戶對市場進行了分類。

按產品分類：

地氟烷

七氟醚

異氟烷

其他

七氟醚佔據市場主導地位

該報告根據產品提供了詳細的市場細分和分析。這包括地氟烷、七氟烷、異氟烷等。根據該報告，七氟烷是最大的部分。

七氟醚的受歡迎很大程度上是由於其良好的藥物動力學特徵。憑藉其快速誘導和甦醒的特點，七氟烷使麻醉師能夠引導患者快速、平穩地進入和退出麻醉。這不僅提高了醫療環境的運作效率，還確保患者在手術開始和結束時經歷的延遲最小。此外，七氟醚的低血氣溶解度可以實現肺部和血流之間的快速平衡，從而更快地調整麻醉深度並有可能更快地恢復。七氟醚引起器官毒性或損害生命功能的可能性降低，為醫療專業人員和患者提供了一定程度的安心。這項安全性對於鞏固七氟醚作為吸入麻醉實踐基石的作用至關重要，特別是在安全性至關重要的兒科和老年人群中。

按應用分類：

就職

維護

維護主導市場

該報告根據應用程式提供了詳細的市場細分和分析。這包括歸納和維護。根據該報告，維護是最大的部分。

維護階段的重要性歸因於其在確保患者舒適度、手術精確度和最佳結果方面的作用。一旦患者被誘導進入麻醉狀態並進行初始手術切口，保持適當的麻醉深度就變得至關重要。麻醉人員仔細滴定吸入麻醉劑，以平衡患者對疼痛完全不敏感的需求，同時避免過度鎮靜，過度鎮靜可能導致併發症或延長恢復時間。這種動態平衡需要在整個過程中持續監測和調整，這凸顯了熟練麻醉師的重要性。此外，維持階段與手術效果和精確度直接相關。外科醫生依靠患者充分麻醉和固定來準確地執行精細的手術。維持階段麻醉深度的任何波動都可能導致患者移動或意識不清，這可能會影響手術的成功。

按最終用戶分類：

醫院

門診手術中心

其他

醫院主導市場

該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院、門診手術中心等。報告稱，醫院佔最大部分。

醫院提供多樣化的醫療服務，包括常規手術、緊急干預以及各個醫學專業的專門手術。醫院進行的外科手術數量龐大、種類繁多，對麻醉服務產生了巨大的需求，而吸入麻醉能夠提供快速誘導和可調節鎮靜水平，與醫院手術室的動態環境無縫結合。此外，醫院也為麻醉管理和病患照護提供全面的基礎設施。他們擁有設備齊全的手術室、先進的監測系統以及能夠處理各種病例的經驗豐富的麻醉團隊。這種強大的設置使醫院能夠有效管理與不同手術相關的複雜性，包括需要吸入麻醉的手術。此外，醫院內專門部門的存在，例如兒科和心臟外科部門，凸顯了吸入麻醉在不同病患群體和程序要求中的多功能性。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的吸入麻醉市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）、亞太地區（中國、日本、印度、韓國、澳洲、印尼等）、歐洲（德國） 、法國、英國、義大利、西班牙、俄羅斯等）、拉丁美洲（巴西、墨西哥等）以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

北美的特點是重視醫療進步和創新。著名研究機構、學術醫療中心和尖端製藥公司的存在創造了一個有利於開發新型麻醉劑、給藥方法和監測技術的環境。這種對創新的承諾不僅改善了患者護理，還吸引了醫療保健專業人員採用最先進的麻醉實踐，包括吸入麻醉技術。該地區的監管環境和對嚴格安全標準的遵守進一步增強了其主導地位。美國食品藥物管理局 (FDA) 等監管機構在確保麻醉劑和設備的安全性和有效性方面發揮關鍵作用。這種嚴格的監督增強了醫療保健提供者和患者對使用吸入麻醉的信心，鞏固了北美作為該領域領導者的地位。此外，北美對醫學教育和培訓的重視確保了麻醉提供者能夠安全有效地實施吸入麻醉。

競爭格局：

製藥和醫療器材公司正在大力投資研發，以創造先進的麻醉劑、輸送系統和監測技術。此外，該公司經常推出新的吸入麻醉產品和設備，以滿足醫療保健提供者和患者不斷變化的需求。這些產品通常採用最新的技術進步，例如更精確的汽化器、整合監控系統和使用者友善的介面。此外，領先企業正在專注於開發創新技術，以加強吸入麻醉的管理和監測。這包括整合電子病歷 (EMR) 系統、即時資料分析和遠端監控功能，以確保最佳的患者護理和安全。此外，許多公司正在為醫療保健專業人員提供培訓和教育計劃，包括麻醉師、護理麻醉師和手術室工作人員。這些計劃有助於確保醫療保健提供者精通與吸入麻醉相關的最新技術、技術和安全措施。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

艾伯維公司

百特國際公司

費森尤斯股票公司

鹵碳產品公司

希克馬製藥公司

魯南製藥集團股份有限公司

默克公司

皮拉馬爾企業有限公司

Troikaa 製藥有限公司

最近的發展：

2023 年 5 月，Piramal Enterprises Ltd 與 plus Therapeutics 合作，以滿足正在進行和計劃中的臨床試驗的研究藥物需求的成長。

2023 年 4 月，百特國際公司推出了 Zosyn Premix。適用於治療敏感細菌引起的多種感染。

2021年12月，Hikma Pharmaceuticals PLC推出鹽酸布比卡因注射液。鹽酸布比卡因注射液適用於成人，用於手術、牙科和口腔手術、診斷和治療程序以及產科手術中產生局部或區域麻醉或鎮痛。

本報告回答的關鍵問題

  • 2022年全球吸入麻醉市場規模有多大
  • 2023-2028年全球吸入麻醉市場的預期成長率是多少
  • 推動全球吸入麻醉市場的關鍵因素是什麼
  • COVID-19 對全球吸入麻醉市場有何影響
  • 基於產品的全球吸入麻醉市場的細分是什麼
  • 基於應用的全球吸入麻醉市場的細分如何
  • 基於最終用戶的全球吸入麻醉市場的細分是什麼
  • 全球吸入麻醉市場的重點區域有哪些
  • 誰是全球吸入麻醉市場的主要參與者/公司

本報告回答的關鍵問題

  • 2022年全球吸入麻醉市場規模有多大？
  • 2023-2028年全球吸入麻醉市場的預期成長率是多少？
  • 推動全球吸入麻醉市場的關鍵因素是什麼？
  • COVID-19 對全球吸入麻醉市場有何影響？
  • 基於該產品的全球吸入麻醉市場的詳細情形如何？
  • 根據應用，全球吸入麻醉市場的細分如何？
  • 基於最終用戶的全球吸入麻醉市場的詳細情形如何？
  • 全球吸入麻醉市場的重點區域有哪些？
  • 全球吸入麻醉市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球吸入麻醉市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 地氟烷
    • 市場走向
    • 市場預測
  • 七氟醚
    • 市場走向
    • 市場預測
  • 異氟烷
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 就職
    • 市場走向
    • 市場預測
  • 維護
    • 市場走向
    • 市場預測

第 8 章：最終用戶的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC
    • Lunan Pharmaceutical Group Co. Ltd
    • Merck KGaA
    • Piramal Enterprises Ltd.
    • Troikaa Pharmaceuticals Ltd
Product Code: SR112023A3998

Abstract

The global inhalation anesthesia market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2022-2028. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.

Inhalation anesthesia is a medical technique employed to induce a reversible state of unconsciousness and insensitivity to pain in patients undergoing various surgical procedures. This method involves administering anesthetic agents in the form of gases or vapors through a breathing mask or an endotracheal tube placed in the patient's airway. These anesthetic agents, such as nitrous oxide, sevoflurane, isoflurane, and desflurane, are carefully balanced to achieve the desired level of sedation and pain relief while maintaining vital bodily functions. The inhaled anesthetics travel through the patient's respiratory system, reaching the lungs and then entering the bloodstream, eventually affecting the brain and central nervous system.

The increasing prevalence of chronic medical disorders requiring surgical treatments is driving the global market. Moroever, as economies develop and individuals have better access to healthcare services, healthcare expenditure tends to increase. This includes investments in medical equipment and technologies, including anesthesia equipment. Governments and private healthcare providers are willing to invest in state-of-the-art equipment to improve patient care and safety. Moroever, regulations, and guidelines related to patient safety and anesthesia practices can impact the types of anesthesia agents and equipment used. Market growth is often aligned with compliance with these regulations, which can lead to the adoption of newer technologies and agents. Also, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions can lead to the development and promotion of new anesthesia technologies, impelling market expansion. Furthermore, the availability of skilled anesthesia professionals is crucial for administering inhalation anesthesia safely and effectively. Training programs and efforts to maintain a competent anesthesia workforce can impact the demand for these techniques.

Inhalation Anesthesia Market Trends/Drivers:

Continual Advancements in Anesthetic Agents and Delivery Systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.

Rising Surgical Procedures and Patient Volume

Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient's unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.

Expansion of Ambulatory Surgical Centers

ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.

Inhalation Anesthesia Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Desflurane

Sevoflurane

Isoflurane

Others

Sevoflurane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.

Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.

Breakup by Application:

Induction

Maintenance

Maintenance dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.

The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest inhalation anesthesia market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbvie Inc.

Baxter International Inc.

Fresenius SE & Co. KGaA

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

Lunan Pharmaceutical Group Co. Ltd

Merck KGaA

Piramal Enterprises Ltd.

Troikaa Pharmaceuticals Ltd.

Recent Developments:

In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.

In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.

In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.

Key Questions Answered in This Report

  • 1. What was the size of the global inhalation anesthesia market in 2022?
  • 2. What is the expected growth rate of the global inhalation anesthesia market during 2023-2028?
  • 3. What are the key factors driving the global inhalation anesthesia market?
  • 4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
  • 5. What is the breakup of the global inhalation anesthesia market based on the product?
  • 6. What is the breakup of the global inhalation anesthesia market based on the application?
  • 7. What is the breakup of the global inhalation anesthesia market based on the end user?
  • 8. What are the key regions in the global inhalation anesthesia market?
  • 9. Who are the key players/companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Desflurane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sevoflurane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Isoflurane
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Induction
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Maintenance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Halocarbon Products Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Hikma Pharmaceuticals PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KGaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Piramal Enterprises Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Troikaa Pharmaceuticals Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
  • Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
  • Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
  • Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
  • Table 7: Global: Inhalation Anesthesia Market: Key Players